Vision / R&D
Leadership
Finance / Economy
Talent / People / Culture
Innovation / Livability
Smart policies / Tax incentives
Sustainability
Social impact
| Net Income | GB£ 5.749 billion |
|---|
| Revenue | GB£ 34.099 billion |
|---|
| Industry/Categories | Pharmaceutical, Biotechnology, Consumer goods |
|---|
| Traded as | GSK |
|---|
| Number of employees | 99,437 (2019) |
|---|
| Products | Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines |
|---|
| Key People | Jonathan Symonds (Chairperson) | Emma Walmsley (CEO) |
|---|
| Operating Status | Active |
|---|
| Headquarters | London, England, UK |
|---|
| Type | Public limited company |
|---|
| Established | 2000 |
|---|
Own or work here?Summary
The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people.
GSK’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies.
History
Established in 2000, by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world’s sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016, it had a market capitalisation of £81 billion (about US$107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.
Vision
The opportunity to make a difference to millions of lives every day. GSK Consumer Healthcare follows its core values of keeping consumers first, demonstrating respect for people, acting with integrity, and operating with transparency. We are proud of our commitment that enables us to enhance the quality of peoples lives and helps us provide them with quality products.
Mission
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
References
https://www.gsk.com/en-gb/home/
https://www.crunchbase.com/organization/glaxosmithkline
https://en.wikipedia.org/wiki/GlaxoSmithKline
https://www.comparably.com/companies/gsk/mission
Hernaldo Turrillo is a writer and author specialised in innovation, AI, DLT, SMEs, trading, investing and new trends in technology and business. He has been working for ztudium group since 2017. He is the editor of openbusinesscouncil.org, tradersdna.com, hedgethink.com, and writes regularly for intelligenthq.com, socialmediacouncil.eu. Hernaldo was born in Spain and finally settled in London, United Kingdom, after a few years of personal growth. Hernaldo finished his Journalism bachelor degree in the University of Seville, Spain, and began working as reporter in the newspaper, Europa Sur, writing about Politics and Society. He also worked as community manager and marketing advisor in Los Barrios, Spain. Innovation, technology, politics and economy are his main interests, with special focus on new trends and ethical projects. He enjoys finding himself getting lost in words, explaining what he understands from the world and helping others. Besides a journalist, he is also a thinker and proactive in digital transformation strategies. Knowledge and ideas have no limits.
Member/Partner of
